New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Qua

New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA

New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Spain , Barcelona , Comunidad Autonoma De Cataluna , Jay Backstrom , Ariane Lovell , Rushmie Nofsinger , Basil Darras , Scholar Rock Inc , International Scientific Congress , Linkedin , Twitter , Drug Administration , Harvard Medical School , Exchange Commission , European Medicines Agency , Associate Neurologist In Chief , Boston Children , Chief Executive Officer , Pediatric Evaluation , Disability Inventory Computer Adaptive Test , Reported Outcome Measurement Information System , Shuttle Box , Block Test , Revised Upper Limb Module , Hammersmith Functional Motor Scale Expanded , Revised Hammersmith Scale , Fast Track , Orphan Drug , Rare Pediatric Disease , Priority Medicines , Orphan Medicinal Product , Scholar Rock , Securities Act , Private Securities Litigation Reform Act , Quarterly Report , Physical Therapists , Clinical Evaluators , Spinal Muscular Atrophy ,